Ginkgo Bioworks Holdings, Inc. (DNA) short interest & options flow
NYSEGinkgo Bioworks faces its sharpest test of its recent rally. The stock fell 7.6% on Wednesday to $11.47, cutting its one-week loss to 10.6%, even as it retains a 65% gain over the past month. Short sellers have been rebuilding positions steadily through that rally, and the pace is now accelerating. Short interest climbed to 16.6% of free float on Wednesday, up 31% over the past…
DNA cost to borrow surges to 2.55%, up nearly 400% in one week as short interest climbs to 16.2% of float.
- Market cap
- $760M
- Next earnings
- 25 Feb 2027
Key data as of 7 Nov 2026
Latest signals on DNA
- Cost to Borrow
DNA cost to borrow surges to 2.55%, up nearly 400% in one week as short interest climbs to 16.2% of float.
DNA news and analysis
RSSNo long-form analysis yet for DNA. Pulse alerts and the live data picture are available on ORTEX.
Open DNA on ORTEX →Want the live picture for DNA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DNA — free to start on ORTEX.
Sign up for free →Open DNA on ORTEX